Difference between revisions of "Colorectal adenocarcinoma"
(redirect) |
(split-out) |
||
Line 1: | Line 1: | ||
# | '''Colorectal adenocarcinoma''' is very common and a leading cause of death due to [[cancer]]. This article deals with ''colorectal adenocarcinoma not otherwise specified''. | ||
''Colorectal carcinoma'', abbreviated ''CRC'', is typically considered a synonym. | |||
==General== | |||
*Very common. | |||
*Rectum and sigmoid > proximal large bowel. | |||
Presentation: | |||
*Bright red blood per rectum (BRBPR). | |||
*Constipation. | |||
*Symptoms of bowel obstruction - nausea, vomiting. | |||
Pathogenesis - see ''[[Colorectal_tumours#Pathogenesis_of_colorectal_carcinoma|pathogenesis of colorectal carcinoma]]''. | |||
==Gross== | |||
Often circumferential or near circumferential: | |||
*These are referred to as "apple core lesion" ''or'' "napkin-ring" lesion. | |||
Mucosa: | |||
*Granular appearance. | |||
*Raised (exophytic) ''or'' heaped edges with ulceration. | |||
Note: | |||
*''Total mesorectal excisions'' should be assessed for completeness. | |||
*The (soft tissue) radial margins, as present in TMEs and right hemicolectomies, should be inked.<ref>URL: [http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13954 http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13954]. Accessed on: 6 February 2013. </ref><ref name=pmid15790712>{{Cite journal | last1 = Bateman | first1 = AC. | last2 = Carr | first2 = NJ. | last3 = Warren | first3 = BF. | title = The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin? | journal = J Clin Pathol | volume = 58 | issue = 4 | pages = 426-8 | month = Apr | year = 2005 | doi = 10.1136/jcp.2004.019802 | PMID = 15790712 }}</ref> | |||
===Images=== | |||
<gallery> | |||
Image:Colon_cancer.jpg | CRC - gross. (WC) | |||
Image:Colon_cancer_2.jpg | CRC - gross. (WC) | |||
</gallery> | |||
<gallery> | |||
Image:Rectum - anterior view.jpg | Rectum - anterior view. (WC) | |||
Image:Rectum - lateral_view.jpg | Rectum - lateral view. (WC) | |||
Image:Rectum - anterior and lateral - inked.jpg| Rectum - inked. (WC) | |||
Image:Rectum - opened.jpg | Rectum - opened (WC) | |||
</gallery> | |||
==Microscopic== | |||
Features: | |||
*Nuclear atypia: | |||
**Nuclear pseudostratification. | |||
**Nuclear hyperchromasia. | |||
**Chromatin clearing or granularity. | |||
*+/-Necrosis. | |||
*Architecture - important for grading: | |||
**Glands. | |||
**Sheets. | |||
===Images=== | |||
<gallery> | |||
Image:Cecal adenocarcinoma.jpg | Cecal adenocarcinoma. (WC) | |||
Image:Colonic_mucinous_adenocarcinoma_-_very_low_mag.jpg | [[Mucinous adenocarcinoma]] - very low mag. (WC/Nephron) | |||
Image:Colonic_mucinous_adenocarcinoma_-_low_mag.jpg | Mucinous adenocarcinoma - low mag. (WC/Nephron) | |||
Image:Adenocarcinoma_coli.jpg | Colorectal adenocarcinoma. (WC) | |||
Image:Crc_met_to_node1.jpg | CRC [[lymph node metastasis]]. (WC/Nephron) | |||
</gallery> | |||
www: | |||
*[http://www.flickr.com/photos/euthman/2480926690/in/set-72057594114099781 Colorectal adenocarcinoma (flickr.com/euthman)]. | |||
===Grading=== | |||
Based on component composed of glands: | |||
*>=50% of tumour = low-grade (''well-differentiated'' and ''moderately differentiated''). | |||
*<50% of tumour = high-grade (''poorly-differentiated'' and ''undifferentiated''). | |||
===Peritumour lymphocytic response=== | |||
*[[AKA]] ''Crohn's-like lymphoid reaction''. | |||
*[[AKA]] ''Crohn's like reaction''.<ref name=pmid19825961>{{Cite journal | last1 = Ogino | first1 = S. | last2 = Nosho | first2 = K. | last3 = Irahara | first3 = N. | last4 = Meyerhardt | first4 = JA. | last5 = Baba | first5 = Y. | last6 = Shima | first6 = K. | last7 = Glickman | first7 = JN. | last8 = Ferrone | first8 = CR. | last9 = Mino-Kenudson | first9 = M. | title = Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. | journal = Clin Cancer Res | volume = 15 | issue = 20 | pages = 6412-20 | month = Oct | year = 2009 | doi = 10.1158/1078-0432.CCR-09-1438 | PMID = 19825961 }}</ref> | |||
*[[AKA]] ''Crohn-like repsonse''.<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2012/Colon_12protocol_3200.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2012/Colon_12protocol_3200.pdf]. Accessed on: 14 September 2012.</ref> | |||
====General==== | |||
*Finding associated with improved survival in CRC.<ref name=pmid7821914 >{{Cite journal | last1 = Harrison | first1 = JC. | last2 = Dean | first2 = PJ. | last3 = el-Zeky | first3 = F. | last4 = Vander Zwaag | first4 = R. | title = Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. | journal = Hum Pathol | volume = 26 | issue = 1 | pages = 31-8 | month = Jan | year = 1995 | doi = | PMID = 7821914 }}</ref> | |||
====Microscopic==== | |||
[[Onlinepathology]] advocates use of the Ueno criteria. They have a better inter-rater reproducibility than the older Graham criteria<ref name=pmid2362940/> and are less complicated. | |||
=====Ueno criteria (2013)===== | |||
Required criteria:<ref name=pmid23525613>{{Cite journal | last1 = Ueno | first1 = H. | last2 = Hashiguchi | first2 = Y. | last3 = Shimazaki | first3 = H. | last4 = Shinto | first4 = E. | last5 = Kajiwara | first5 = Y. | last6 = Nakanishi | first6 = K. | last7 = Kato | first7 = K. | last8 = Maekawa | first8 = K. | last9 = Miyai | first9 = K. | title = Objective Criteria for Crohn-like Lymphoid Reaction in Colorectal Cancer. | journal = Am J Clin Pathol | volume = 139 | issue = 4 | pages = 434-41 | month = Apr | year = 2013 | doi = 10.1309/AJCPWHUEFTGBWKE4 | PMID = 23525613 }}</ref> | |||
*Non-MALT lymphoid aggregates (peritumoural) >= 1 mm. | |||
Ignore: | |||
#Muscosa-associated lymphoid tissue (MALT) = mucosal lymphoid aggregates, submucosal lymphoid aggregates adjacent to the musuclaris mucosae. | |||
#Lymph nodes - these have a (fibrous) capsule. | |||
#Irregular shape (not round). | |||
=====Graham criteria (1990)===== | |||
Required criteria:<ref name=pmid2362940>{{Cite journal | last1 = Graham | first1 = DM. | last2 = Appelman | first2 = HD. | title = Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. | journal = Mod Pathol | volume = 3 | issue = 3 | pages = 332-5 | month = May | year = 1990 | doi = | PMID = 2362940 }}</ref> | |||
*Peritumoral: | |||
*#Lymphoid aggregates with germinal centres focally. | |||
*#Stellate fibrosis. | |||
*#No previous clinical and pathologic evidence of [[Crohn's disease]]. | |||
Note: | |||
*Should '''not''' be confused with [[intratumoural lymphocytic response]]. | |||
**The intratumoural lymphocytic response is associated with MSI-H cancers. | |||
=====Images===== | |||
<gallery> | |||
Image:Peritumour lymphocytic response - low mag.jpg | PLR - low mag. (WC) | |||
Image:Peritumour lymphocytic response - intermed mag.jpg | PLR - intermed. mag. (WC) | |||
</gallery> | |||
www: | |||
*[http://jcp.bmjjournals.com/content/62/8/679/F2.large.jpg Peritumour lymphocytic response in endometrial carcinoma (bmjjournals.com)]. | |||
*[http://ajcp.ascpjournals.org/content/134/3/478/F3.expansion.html Peritumour lymphocytic response in CRC (ascpjournals.org)].<ref name=pmid20716806>{{Cite journal | last1 = Ross | first1 = JS. | last2 = Torres-Mora | first2 = J. | last3 = Wagle | first3 = N. | last4 = Jennings | first4 = TA. | last5 = Jones | first5 = DM. | title = Biomarker-based prediction of response to therapy for colorectal cancer: current perspective. | journal = Am J Clin Pathol | volume = 134 | issue = 3 | pages = 478-90 | month = Sep | year = 2010 | doi = 10.1309/AJCP2Y8KTDPOAORH | PMID = 20716806 | URL = http://ajcp.ascpjournals.org/content/134/3/478.full}}</ref> | |||
===Intratumoural lymphocytic response=== | |||
*[[AKA]] '' tumour-infiltrating lymphocytes'', abbreviated ''TILs''. | |||
====General==== | |||
*Finding is suggestive of microsatellite instabillity.<ref name=pmid21114775>{{Cite journal | last1 = Iacopetta | first1 = B. | last2 = Grieu | first2 = F. | last3 = Amanuel | first3 = B. | title = Microsatellite instability in colorectal cancer. | journal = Asia Pac J Clin Oncol | volume = 6 | issue = 4 | pages = 260-9 | month = Dec | year = 2010 | doi = 10.1111/j.1743-7563.2010.01335.x | PMID = 21114775 }}</ref> | |||
**May be seen in the context of [[Lynch syndrome]]. | |||
====Microscopic==== | |||
Features: | |||
*Lymphocytes are between the tumour cells.<ref name=pmid19638537/> † | |||
**Other lymphocytes do not count. | |||
Note: | |||
* † Definitions vary substantially - some authors consider lymphocytes adjacent to the tumour (in the stroma around the tumour cells) "intratumoural".<reF name=pmid9349235>{{Cite journal | last1 = Ropponen | first1 = KM. | last2 = Eskelinen | first2 = MJ. | last3 = Lipponen | first3 = PK. | last4 = Alhava | first4 = E. | last5 = Kosma | first5 = VM. | title = Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. | journal = J Pathol | volume = 182 | issue = 3 | pages = 318-24 | month = Jul | year = 1997 | doi = 10.1002/(SICI)1096-9896(199707)182:3318::AID-PATH8623.0.CO;2-6 | PMID = 9349235 |URL = http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291096-9896%28199707%29182:3%3C318::AID-PATH862%3E3.0.CO;2-6/pdf}}</ref> | |||
=====Images===== | |||
<gallery> | |||
Image:Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_high_mag.jpg | TILs - high mag. (WC/Nephron) | |||
Image:Tumour_infiltrating_lymphocytes_in_colorectal_carcinoma_-_very_high_mag.jpg | TILs - very high mag. (WC/Nephron) | |||
</gallery> | |||
www: | |||
*[http://jcp.bmjjournals.com/content/62/8/679/F3.large.jpg TILs in endometrial carcinoma (bmjjournals.com)].<ref name=pmid19638537>{{Cite journal | last1 = Garg | first1 = K. | last2 = Soslow | first2 = RA. | title = Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. | journal = J Clin Pathol | volume = 62 | issue = 8 | pages = 679-84 | month = Aug | year = 2009 | doi = 10.1136/jcp.2009.064949 | PMID = 19638537 | URL = http://jcp.bmjjournals.com/content/62/8/679.full?related-urls=yes&legid=jclinpath;62/8/679 }}</ref> | |||
*[http://ajcp.ascpjournals.org/content/134/3/478/F2.expansion.html TILs in CRC (ascpjournals.org)].<ref name=pmid20716806/> | |||
===Tumour deposits=== | |||
*[[AKA]] ''discoutinuous extramural extension''. | |||
*[[AKA]] ''peritumoral deposits''. | |||
====General==== | |||
*Poor prognosticator. | |||
**Can be understood as a type of invasive front/border, e.g. ''well-circumscribed border'' versus ''infiltrative border''.<ref name=pmid24112678/> | |||
*No standardized criteria for tumour deposits.<ref name=pmid24112678>{{Cite journal | last1 = Ueno | first1 = H. | last2 = Hashiguchi | first2 = Y. | last3 = Shimazaki | first3 = H. | last4 = Shinto | first4 = E. | last5 = Kajiwara | first5 = Y. | last6 = Nakanishi | first6 = K. | last7 = Kato | first7 = K. | last8 = Maekawa | first8 = K. | last9 = Nakamura | first9 = T. | title = Peritumoral deposits as an adverse prognostic indicator of colorectal cancer. | journal = Am J Surg | volume = | issue = | pages = | month = Oct | year = 2013 | doi = 10.1016/j.amjsurg.2013.04.009 | PMID = 24112678 }}</ref> | |||
Ueno ''et al.'' propose that a tumour deposit is either:<ref name=pmid24112678/> | |||
#>=2 mm from the tumour front | |||
#>=2 mm (radially) from the deepest aspect of the muscularis propria, if the tumour is not present in the section. | |||
===Tumour regression=== | |||
There is a three tiered regression grading system by Ryan ''et al''. for colorectal cancer that has essentially been adopted by [[CAP]]:<ref name=pmid16045774>{{Cite journal | last1 = Ryan | first1 = R. | last2 = Gibbons | first2 = D. | last3 = Hyland | first3 = JM. | last4 = Treanor | first4 = D. | last5 = White | first5 = A. | last6 = Mulcahy | first6 = HE. | last7 = O'Donoghue | first7 = DP. | last8 = Moriarty | first8 = M. | last9 = Fennelly | first9 = D. | title = Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. | journal = Histopathology | volume = 47 | issue = 2 | pages = 141-6 | month = Aug | year = 2005 | doi = 10.1111/j.1365-2559.2005.02176.x | PMID = 16045774 }}</ref> | |||
{| class="wikitable sortable" | |||
! Grade | |||
! Features | |||
|- | |||
| Grade 1 | |||
| small groups of tumour cells or single tumour cells | |||
|- | |||
| Grade 2 | |||
| definite tumour but more fibrosis ("cancer outgrown by fibrosis") | |||
|- | |||
| Grade 3 | |||
| definite tumour with no fibrosis ''or'' tumour with a lesser amount of fibrosis ("fibrosis outgrown by cancer") | |||
|} | |||
==IHC== | |||
*CK7 -ve. | |||
*CK20 +ve. | |||
*CEA +ve. | |||
*CDX2 +ve. | |||
==Molecular== | |||
*KRAS mutation analysis. | |||
**Mutation present ~ 40% of [[CRC]]. | |||
**Mutations in codons 12 or 13 associated with failure of anti-EGFR therapy (e.g. ''cetuximab'', ''panitumumab'').<ref name=pmid19792050>{{Cite journal | last1 = Monzon | first1 = FA. | last2 = Ogino | first2 = S. | last3 = Hammond | first3 = ME. | last4 = Halling | first4 = KC. | last5 = Bloom | first5 = KJ. | last6 = Nikiforova | first6 = MN. | title = The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer. | journal = Arch Pathol Lab Med | volume = 133 | issue = 10 | pages = 1600-6 | month = Oct | year = 2009 | doi = 10.1043/1543-2165-133.10.1600 | PMID = 19792050 }}</ref> | |||
*BRAF mutation analysis. | |||
**''V600E'' missense mutation found in ~10% CRC.<ref name=pmid20635392>{{cite journal |author=Tie J, Gibbs P, Lipton L, ''et al.'' |title=Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAF(V600E) mutation |journal=Int J Cancer |volume= |issue= |pages= |year=2010 |month=July |pmid=20635392 |doi=10.1002/ijc.25555 |url=}}</ref> | |||
Note: | |||
*KRAS mutations and BRAF mutations are considered mutually exclusive as they occur in the same pathway. | |||
==Sign out== | |||
===Right hemicolectomy=== | |||
<pre> | |||
TERMINAL ILEUM, CECUM, ASCENDING COLON AND APPENDIX, RIGHT HEMICOLECTOMY: | |||
- INVASIVE ADENOCARCINOMA WITH A MUCINOUS COMPONENT, LOW-GRADE, pT1, pN0. | |||
-- MARGINS NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | |||
-- PLEASE SEE TUMOUR SUMMARY. | |||
- SMALL BOWEL WALL WITHIN NORMAL LIMITS. | |||
- APPENDIX WITHOUT SIGNIFICANT PATHOLOGY. | |||
- FOURTEEN LYMPH NODES NEGATIVE FOR MALIGNANCY ( 0 POSITIVE / 14 ). | |||
</pre> | |||
==See also== | |||
*[[Colon]]. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||
[[Category:Colorectal tumours]] |
Revision as of 04:00, 7 December 2013
Colorectal adenocarcinoma is very common and a leading cause of death due to cancer. This article deals with colorectal adenocarcinoma not otherwise specified.
Colorectal carcinoma, abbreviated CRC, is typically considered a synonym.
General
- Very common.
- Rectum and sigmoid > proximal large bowel.
Presentation:
- Bright red blood per rectum (BRBPR).
- Constipation.
- Symptoms of bowel obstruction - nausea, vomiting.
Pathogenesis - see pathogenesis of colorectal carcinoma.
Gross
Often circumferential or near circumferential:
- These are referred to as "apple core lesion" or "napkin-ring" lesion.
Mucosa:
- Granular appearance.
- Raised (exophytic) or heaped edges with ulceration.
Note:
- Total mesorectal excisions should be assessed for completeness.
- The (soft tissue) radial margins, as present in TMEs and right hemicolectomies, should be inked.[1][2]
Images
Microscopic
Features:
- Nuclear atypia:
- Nuclear pseudostratification.
- Nuclear hyperchromasia.
- Chromatin clearing or granularity.
- +/-Necrosis.
- Architecture - important for grading:
- Glands.
- Sheets.
Images
Mucinous adenocarcinoma - very low mag. (WC/Nephron)
CRC lymph node metastasis. (WC/Nephron)
www:
Grading
Based on component composed of glands:
- >=50% of tumour = low-grade (well-differentiated and moderately differentiated).
- <50% of tumour = high-grade (poorly-differentiated and undifferentiated).
Peritumour lymphocytic response
General
- Finding associated with improved survival in CRC.[5]
Microscopic
Onlinepathology advocates use of the Ueno criteria. They have a better inter-rater reproducibility than the older Graham criteria[6] and are less complicated.
Ueno criteria (2013)
Required criteria:[7]
- Non-MALT lymphoid aggregates (peritumoural) >= 1 mm.
Ignore:
- Muscosa-associated lymphoid tissue (MALT) = mucosal lymphoid aggregates, submucosal lymphoid aggregates adjacent to the musuclaris mucosae.
- Lymph nodes - these have a (fibrous) capsule.
- Irregular shape (not round).
Graham criteria (1990)
Required criteria:[6]
- Peritumoral:
- Lymphoid aggregates with germinal centres focally.
- Stellate fibrosis.
- No previous clinical and pathologic evidence of Crohn's disease.
Note:
- Should not be confused with intratumoural lymphocytic response.
- The intratumoural lymphocytic response is associated with MSI-H cancers.
Images
www:
- Peritumour lymphocytic response in endometrial carcinoma (bmjjournals.com).
- Peritumour lymphocytic response in CRC (ascpjournals.org).[8]
Intratumoural lymphocytic response
- AKA tumour-infiltrating lymphocytes, abbreviated TILs.
General
- Finding is suggestive of microsatellite instabillity.[9]
- May be seen in the context of Lynch syndrome.
Microscopic
Features:
- Lymphocytes are between the tumour cells.[10] †
- Other lymphocytes do not count.
Note:
- † Definitions vary substantially - some authors consider lymphocytes adjacent to the tumour (in the stroma around the tumour cells) "intratumoural".[11]
Images
www:
Tumour deposits
General
- Poor prognosticator.
- Can be understood as a type of invasive front/border, e.g. well-circumscribed border versus infiltrative border.[12]
- No standardized criteria for tumour deposits.[12]
Ueno et al. propose that a tumour deposit is either:[12]
- >=2 mm from the tumour front
- >=2 mm (radially) from the deepest aspect of the muscularis propria, if the tumour is not present in the section.
Tumour regression
There is a three tiered regression grading system by Ryan et al. for colorectal cancer that has essentially been adopted by CAP:[13]
Grade | Features |
---|---|
Grade 1 | small groups of tumour cells or single tumour cells |
Grade 2 | definite tumour but more fibrosis ("cancer outgrown by fibrosis") |
Grade 3 | definite tumour with no fibrosis or tumour with a lesser amount of fibrosis ("fibrosis outgrown by cancer") |
IHC
- CK7 -ve.
- CK20 +ve.
- CEA +ve.
- CDX2 +ve.
Molecular
- KRAS mutation analysis.
- BRAF mutation analysis.
- V600E missense mutation found in ~10% CRC.[15]
Note:
- KRAS mutations and BRAF mutations are considered mutually exclusive as they occur in the same pathway.
Sign out
Right hemicolectomy
TERMINAL ILEUM, CECUM, ASCENDING COLON AND APPENDIX, RIGHT HEMICOLECTOMY: - INVASIVE ADENOCARCINOMA WITH A MUCINOUS COMPONENT, LOW-GRADE, pT1, pN0. -- MARGINS NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. -- PLEASE SEE TUMOUR SUMMARY. - SMALL BOWEL WALL WITHIN NORMAL LIMITS. - APPENDIX WITHOUT SIGNIFICANT PATHOLOGY. - FOURTEEN LYMPH NODES NEGATIVE FOR MALIGNANCY ( 0 POSITIVE / 14 ).
See also
References
- ↑ URL: http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13954. Accessed on: 6 February 2013.
- ↑ Bateman, AC.; Carr, NJ.; Warren, BF. (Apr 2005). "The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin?". J Clin Pathol 58 (4): 426-8. doi:10.1136/jcp.2004.019802. PMID 15790712.
- ↑ Ogino, S.; Nosho, K.; Irahara, N.; Meyerhardt, JA.; Baba, Y.; Shima, K.; Glickman, JN.; Ferrone, CR. et al. (Oct 2009). "Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.". Clin Cancer Res 15 (20): 6412-20. doi:10.1158/1078-0432.CCR-09-1438. PMID 19825961.
- ↑ URL: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2012/Colon_12protocol_3200.pdf. Accessed on: 14 September 2012.
- ↑ Harrison, JC.; Dean, PJ.; el-Zeky, F.; Vander Zwaag, R. (Jan 1995). "Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis.". Hum Pathol 26 (1): 31-8. PMID 7821914.
- ↑ 6.0 6.1 Graham, DM.; Appelman, HD. (May 1990). "Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator.". Mod Pathol 3 (3): 332-5. PMID 2362940.
- ↑ Ueno, H.; Hashiguchi, Y.; Shimazaki, H.; Shinto, E.; Kajiwara, Y.; Nakanishi, K.; Kato, K.; Maekawa, K. et al. (Apr 2013). "Objective Criteria for Crohn-like Lymphoid Reaction in Colorectal Cancer.". Am J Clin Pathol 139 (4): 434-41. doi:10.1309/AJCPWHUEFTGBWKE4. PMID 23525613.
- ↑ 8.0 8.1 Ross, JS.; Torres-Mora, J.; Wagle, N.; Jennings, TA.; Jones, DM. (Sep 2010). "Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.". Am J Clin Pathol 134 (3): 478-90. doi:10.1309/AJCP2Y8KTDPOAORH. PMID 20716806.
- ↑ Iacopetta, B.; Grieu, F.; Amanuel, B. (Dec 2010). "Microsatellite instability in colorectal cancer.". Asia Pac J Clin Oncol 6 (4): 260-9. doi:10.1111/j.1743-7563.2010.01335.x. PMID 21114775.
- ↑ 10.0 10.1 Garg, K.; Soslow, RA. (Aug 2009). "Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.". J Clin Pathol 62 (8): 679-84. doi:10.1136/jcp.2009.064949. PMID 19638537.
- ↑ Ropponen, KM.; Eskelinen, MJ.; Lipponen, PK.; Alhava, E.; Kosma, VM. (Jul 1997). "Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.". J Pathol 182 (3): 318-24. doi:10.1002/(SICI)1096-9896(199707)182:3318::AID-PATH8623.0.CO;2-6. PMID 9349235.
- ↑ 12.0 12.1 12.2 Ueno, H.; Hashiguchi, Y.; Shimazaki, H.; Shinto, E.; Kajiwara, Y.; Nakanishi, K.; Kato, K.; Maekawa, K. et al. (Oct 2013). "Peritumoral deposits as an adverse prognostic indicator of colorectal cancer.". Am J Surg. doi:10.1016/j.amjsurg.2013.04.009. PMID 24112678.
- ↑ Ryan, R.; Gibbons, D.; Hyland, JM.; Treanor, D.; White, A.; Mulcahy, HE.; O'Donoghue, DP.; Moriarty, M. et al. (Aug 2005). "Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.". Histopathology 47 (2): 141-6. doi:10.1111/j.1365-2559.2005.02176.x. PMID 16045774.
- ↑ Monzon, FA.; Ogino, S.; Hammond, ME.; Halling, KC.; Bloom, KJ.; Nikiforova, MN. (Oct 2009). "The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.". Arch Pathol Lab Med 133 (10): 1600-6. doi:10.1043/1543-2165-133.10.1600. PMID 19792050.
- ↑ Tie J, Gibbs P, Lipton L, et al. (July 2010). "Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAF(V600E) mutation". Int J Cancer. doi:10.1002/ijc.25555. PMID 20635392.